biognosys is a proteomics company specializing in mass spectrometry-based solutions for precise protein quantification and biomarker discovery. its paradigm shifting platform enables the comprehensive analysis of complex biological samples, aiding researchers in understanding cellular processes and diseases. biognosys' patented tools accelerate the drug development process, providing better diagnosis, and allowing patient specific treatment schemes.